| Issue |
E3S Web Conf.
Volume 282, 2021
International Conference “Ensuring Food Security in the Context of the COVID-19 Pandemic” (EFSC2021)
|
|
|---|---|---|
| Article Number | 06006 | |
| Number of page(s) | 6 | |
| Section | Improvement of Technical Regulation, Sanitary-Epidemiological, Veterinary and Phytosanitary Supervision, Control in the Field of Food Safety for Human Health | |
| DOI | https://doi.org/10.1051/e3sconf/202128206006 | |
| Published online | 05 July 2021 | |
The role of colostral immunity in the effectiveness of serological detection of BLV
Federal State Budgetary Scientific Institution «Ural Federal Agrarian Scientific Research Centre, Ural Branch of Russian Academy of Sciences», 620142 Yekaterinburg, Russia
* Corresponding author: petropavlovsky_m@mail.ru
The purpose of our research was to study the influence of newborn calves colostral antibodies on the efficiency of bovine leukemia virus detection by serological methods. The research was conducted on the basis of agricultural organizations within the territory of the Ural Federal District (Chelyabinsk region). We undertook comprehensive diagnostic studies of calves fed with milk from seropositive and seronegative animals using polymerase chain reaction, ELISA test, and immunodiffusion test. Experimentally it was found that feeding calves with milk from seropositive and seronegative cows led to colostral immunoglobulins persistence for up to 3-3.5 months, in most of the animals, which may be associated with the end of suckling period in calves. At the same time, serological screening of animals during this period is difficult due to the influence of a high concentration of colostral antibodies. The obtained results of laboratory studies indicate the efficiency of PCR diagnostics in detecting a specific locus of the calf leukemia virus in animals at the early stages of the infectious process. PCR diagnostics provides an opportunity to early evaluation of calves with a latent course of BLV, excluding the influence of colostral immunity, thereby reducing the recovery time of enterprises from the leukemia virus by 20%.
© The Authors, published by EDP Sciences, 2021
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.